Regoli, François http://orcid.org/0000-0002-5936-4656
,
Graf, Denis
Schaer, Beat
Duru, Firat
Ammann, Peter
Stefano, Lorenza Mangoni di S.
Naegli, Barbara
Burri, Haran
Zbinden, Rainer
Krasniqi, Nazmi
Fromer, Martin
Funding for this research was provided by:
Medtronic
Article History
Received: 31 December 2018
Accepted: 27 May 2019
First Online: 17 June 2019
Ethics approval and consent to participate
: Ethical Review Board approval was obtained prior to study start from the corresponding institutions of all participating centers (Ethical Board of Tessin reference number: CE 2539). Every patient gave their written informed consent for participation in the study.
: Not applicable.
: Dr. François Regoli declares speaker and consultation fees from Bayer, Boston Scientific, Microport, Medtronic, and is associate editor for BMC Cardiovascular Disorders. Dr. Beat Schaer discloses speaker’s bureau fees from Medtronic and Microport. Dr. Peter Ammann is a European advisory board member for Medtronic. Lorenza Mangoni di S. Stefano is an employee of Medtronic Core Clinical Solutions. Dr. Martin Fromer is a consultant for Medtronic, Switzerland. Doctors Denis Graf, Firat Duru, Barbara Naegli, Haran Burri, Rainer Zbinden, Nazmi Krasniqi have no competing interests to declare.